Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) was the target of some unusual options trading activity on Wednesday. Investors bought 1,885 put options on the company. This represents an increase of approximately 1,101% compared to the average volume of 157 put options.
Evelo Biosciences Price Performance
Shares of EVLO stock opened at $0.00 on Friday. The company has a market cap of $9,420.00, a price-to-earnings ratio of 0.00 and a beta of 0.47. Evelo Biosciences has a 12-month low of $0.00 and a 12-month high of $0.00.
Evelo Biosciences Company Profile
Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered immunomodulatory therapies that leverage the gut-body network. The company’s proprietary platform is designed to mimic signals normally generated by gut commensal bacteria to regulate immune function throughout the body. Evelo’s approach focuses on non-live, inactivated microbial derivatives, aiming to offer a new class of biologics that can be administered by mouth and engage mucosal immune pathways to treat a range of diseases.
The company’s pipeline spans inflammatory, autoimmune and oncology indications.
Read More
- Five stocks we like better than Evelo Biosciences
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
